PRISMACCESS
DEAD

Serial Number

79194037

Owner

IQVIA Operations France SAS

Attorney

JONATHAN Z KING

Filing Date

Jul 1, 2016

Add to watchlist:

No watchlists yet
View on USPTO

PRISMACCESS Trademark

Serial Number: 79194037

PRISMACCESS is a trademark filed by IQVIA Operations France SAS on July 1, 2016. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

IQVIA Operations France SAS

Tour D2,

Entity Type: 98

PRIORITIS, SAS

12 avenue Victor Hugo

Entity Type: 03

Trademark Details

Filing Date

July 1, 2016

Registration Date

Not Registered

Published for Opposition

March 12, 2019

Goods & Services

Education services, namely, workshops, webinars, seminars, expert's panel discussions in the field of pharmaceutical data, whether medical, legal, regulatory and/or economic; providing training in the field of understanding and collecting pharmaceutical data, whether medical, legal, regulatory and/or economic; organization and conducting of educational colloquiums, conferences or congresses in the field of understanding and collecting pharmaceutical data, whether medical, legal, regulatory and/or economic

Software being recorded programs for use in database management, management and classification of pharmaceutical information and data; software and applications for mobile devices for use in database management, management and classification of pharmaceutical information and data; data communication software for providing scientific and/or economic and/or legal information and data on pharmaceutical proprietary products; computer software for use in data collection, data management and data analysis of pharmaceutical, medical, health-economy and healthcare information ; computer software for use in data collection in the fields clinical trials analysis, market access and Health Technology Assessment (HTA) decisions, Price and Reimbursement (PandR) decisions; computer software for web-based access to data, data collection, data analysis, data integration and preparation of reports in connection with pharmaceutical, medical and health information; downloadable computer software in the form of mobile applications for web-based access to data, data collection, data analysis, data integration and preparation of reports in connection with pharmaceutical, medical and health information

Printing products being printed matter, namely, leaflets, posters and brochures providing pharmaceutical data, whether scientific, legal, regulatory and/or economic to the pharmaceutical industry; printed instructional or teaching material except apparatus in the field of delivering pharmaceutical data, whether scientific, legal, regulatory and/or economic to medical practitioners and members of the pharmaceutical industry; newspapers

Business management and business consultation in the pharmaceutical, medical, and healthcare fields; business consultation in the field of clinical research and clinical trials, namely, assist pharmaceutical companies with clinical trials approval issues for medicinal products and medical devices; business consultation in the field of market access and submission management, namely, assist pharmaceutical companies on Health Technology Assessment (HTA) and Pricing and Reimbursement (PandR) procedures for medicinal products and medical devices; consultation in the field of data processing and database management services for collection of scientific, economic and regulatory data in the field of medicinal products and medical devices; web-based portal providing business information on medicinal products and medical devices, namely, marketing activities and launching strategies; computerized data management in the pharmaceutical, medical, and healthcare fields; computerized file management in the pharmaceutical, medical, and healthcare fields

Providing medical, pharmaceutical, health management, and disease management information relating to pharmaceutical products to others

Software design; research and development of new products for others; technical project studies in the field of new technologies in the field of pharmaceutical data; software maintenance; software installation; software rental; updating of software; scientific and technological analyses, namely, scientific and technological consultancy in relation to the development, validation, and regulatory approval of pharmaceutical drugs, biologics, and medical devices; scientific and technological analyses, namely, scientific and technological consultancy on Health Technology Assessment (HTA), clinical development, Pricing and Reimbursement (PandR) strategies, scientific, legal, regulatory and economic information on pharmaceutical drugs, biologics, and medical devices; design of computer software featuring decision-making tools for the pharmaceutical industry on pharmaceutical drugs, biologics, and medical devices; design of computer systems in the pharmaceutical, medical, and healthcare fields; on-line interactive database featuring scientific research information, on pharmaceutical drugs, biologics, and medical devices in the pharmaceutical, medical, and healthcare fields; technical data analysis services, namely, data mining in the field of pharmaceutical data, whether scientific, legal, regulatory and/or economic; advice relating to information technology intended for the pharmaceutical and health industries

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Jan 30, 2025 CHLD
NEW REPRESENTATIVE AT IB RECEIVED
Nov 22, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 5, 2023 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Feb 14, 2023 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 14, 2023 FICR
ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Feb 14, 2022 MAB4
ABANDONMENT - AFTER INTER PARTES DECISION
Feb 14, 2022 ABN4
OPPOSITION TERMINATED NO. 999999
Feb 14, 2022 OP.T
OPPOSITION SUSTAINED NO. 999999
Feb 14, 2022 OP.S
REFUSAL PROCESSED BY IB
May 3, 2019 RFNT
NOTIFICATION PROCESSED BY IB
Apr 26, 2019 GPNX
OPPOSITION INSTITUTED NO. 999999
Apr 15, 2019 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Apr 12, 2019 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Apr 12, 2019 OPNC
OPPOSITION PAPERS RECEIVED AT TTAB
Apr 11, 2019 OPPF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 12, 2019 NPUB
PUBLISHED FOR OPPOSITION
Mar 12, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 20, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 20, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 20, 2019 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 5, 2019 PREV
ASSIGNED TO LIE
Feb 3, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 22, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 21, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 21, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 21, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 9, 2018 GNFN
FINAL REFUSAL E-MAILED
Aug 9, 2018 GNFR
FINAL REFUSAL WRITTEN
Aug 9, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 13, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 13, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 13, 2018 TROA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 6, 2018 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 21, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 21, 2018 OPNR
REFUSAL PROCESSED BY IB
Mar 9, 2018 RFNP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 13, 2018 GNRN
NON-FINAL ACTION E-MAILED
Jan 13, 2018 GNRT
NON-FINAL ACTION WRITTEN
Jan 13, 2018 CNRT
NOTICE OF REINSTATEMENT MAILED
Dec 22, 2017 MREI
REINSTATED
Dec 20, 2017 REIN
PETITION TO DIRECTOR GRANTED
Dec 20, 2017 PCGR
ASSIGNED TO PETITION STAFF
Dec 4, 2017 APET
TEAS PETITION TO DIRECTOR RECEIVED
Aug 31, 2017 TPDR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 6, 2017 TCCA
ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE
Jul 3, 2017 MAB0
ABANDONMENT - INCOMPLETE RESPONSE
Jul 3, 2017 ABN0
NOTICE OF UNRESPONSIVE AMENDMENT - MAILED
May 15, 2017 NAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
May 15, 2017 NAUD
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 25, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 25, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 25, 2017 TROA
REFUSAL PROCESSED BY IB
Nov 18, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 28, 2016 RFCS
REFUSAL PROCESSED BY MPU
Oct 28, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 28, 2016 RFCR
NON-FINAL ACTION WRITTEN
Oct 27, 2016 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 25, 2016 MAFR
ASSIGNED TO EXAMINER
Oct 21, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 21, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 20, 2016 REPR